Glioblastoma-Derived Mechanisms of Systemic Immunosuppression
Author:
- 1 January 2010
- journal article
- review article
- Published by Elsevier in Neurosurgery Clinics of North America
- Vol. 21 (1) , 31-42
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- Myeloid-Derived Suppressor Cells: Linking Inflammation and CancerThe Journal of Immunology, 2009
- Dynamics of central and peripheral immunomodulation in a murine glioma modelBMC Immunology, 2009
- The Many Roles of FAS Receptor Signaling in the Immune SystemImmunity, 2009
- Chapter 8 The Role of NKT Cells in Tumor Immunity2008
- Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progressionJournal of Neuro-Oncology, 2007
- CD39 and control of cellular immune responsesPurinergic Signalling, 2007
- An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme1Neuro-Oncology, 2006
- Natural regulatory T cells in infectious diseaseNature Immunology, 2005
- The eicosanoid cascade: possible role in gliomas and meningiomas: Figure 1Journal of Clinical Pathology, 2003
- Enhanced expression of transforming growth factor‐β and its type‐I and type‐II receptors in human glioblastomaInternational Journal of Cancer, 1995